Rapport Therapeutics, Inc. RAPP

Set alert

Price alert · RAPP

All alert types
25.14 USD +0.01 +0.04%

As of Nov 3, 11:52 AM ET

Bid
25.13 × 1
Ask
25.20 × 1
25.13 Day range 26.06
22.50 52-week range 52.50
YTD
-17.14%
1 year
-6.68%
Open
25.39
Prev close
25.13
Mkt cap
1.45B
Vol
169.18K
Avg vol
712.76K
EPS
-3.03
P/E
0.00
Div yield
0.00%
More statistics
Low
25.13
High
26.06
Forward P/E
-4.94
Beta
1.40
Short ratio
6.70
Inst. own
96.71%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
36.70
200-d avg
35.65
1y target
68.29

MAX chart

Chart tools
Interval

Events in this range
  • Aug 7, 2025Earnings: -0.75; estimate -0.87; surprise 13.79%
  • Nov 6, 2025Earnings: -0.71; estimate -0.77; surprise 7.79%
  • Mar 10, 2026Earnings: -0.72; estimate -0.65; surprise -10.77%
  • May 7, 2026Earnings: -0.42; estimate -0.56; surprise 25%
  • Aug 5, 2026Earnings: -1.19; estimate -0.96311; surprise -23.56%
  • Oct 15, 2026Rating: UBS · — → Buy
  • Oct 20, 2026Rating: BTIG · Buy → Buy
  • Oct 20, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Oct 21, 2026Rating: Guggenheim · Buy → Buy
  • Oct 21, 2026Rating: Wells Fargo · Overweight → Overweight
  • Oct 21, 2026Rating: Jones Trading · Buy → Buy
  • Nov 5, 2026Earnings: —; estimate -1.2; surprise —%
Signals (35)
NameDateAgo
SMA: BearishSep 21, 20261 month ago
MACD: Sell SignalSep 14, 20261 month ago
SMA: BearishSep 7, 20261 month ago
RSI: OverboughtAug 17, 20262 months ago
SMA: BullishJun 22, 20264 months ago
SMA: BearishJun 15, 20264 months ago
SMA: BullishJun 8, 20264 months ago
SMA: BearishJun 1, 20265 months ago
RSI: OverboughtApr 13, 20266 months ago
MACD: Buy SignalApr 6, 20267 months ago
SMA: BullishMar 30, 20267 months ago
SMA: BearishMar 9, 20267 months ago
SMA: BullishFeb 16, 20268 months ago
SMA: BearishJan 12, 20269 months ago
SMA: BullishJan 5, 202610 months ago
MACD: Sell SignalJan 5, 202610 months ago
SMA: BearishDec 29, 202510 months ago
SMA: BullishNov 17, 202511 months ago
SMA: BearishNov 10, 202511 months ago
RSI: OverboughtSep 15, 20251 year ago

Newest 20 of 35.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 68.29 +171.6% upside
Target (low)
50.00
Target (mean)
68.29
Target (high)
91.00
Ratings (0m) 16 16 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy15
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 16
  • 1 month ago 13
  • 2 months ago 13

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

RAPP analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-1.22-1.36 – -1.08-0.71-72.1%00.0%12
Next quarter-1.20-1.54 – -0.81-0.72-66.2%66.67K0.0%12
Current year-4.04-4.51 – -3.50-2.86-41.2%20.06M0.0%12
Next year-5.09-6.80 – -3.81-4.04-26.0%0-100.0%12

Upgrades and downgrades

The latest rating changes

RAPP analyst upgrades and downgrades
DateFirmActionFromTo
Oct 21, 2026Jones TradingMaintainedBuyBuy
Oct 21, 2026Wells FargoMaintainedOverweightOverweight
Oct 21, 2026GuggenheimMaintainedBuyBuy
Oct 20, 2026HC Wainwright & Co.ReiteratedBuyBuy
Oct 20, 2026BTIGMaintainedBuyBuy
Oct 15, 2026UBSInitiated—Buy
Oct 15, 2026Wolfe ResearchInitiated—Outperform
Oct 6, 2026GuggenheimInitiated—Buy
Sep 16, 2026BTIGMaintainedBuyBuy
Aug 19, 2026BTIGReiteratedBuyBuy
Aug 12, 2026HC Wainwright & Co.MaintainedBuyBuy
Aug 5, 2026BTIGReiteratedBuyBuy
Jul 16, 2026BTIGReiteratedBuyBuy
Jun 24, 2026Leerink PartnersInitiated—Outperform
May 21, 2026BTIGMaintainedBuyBuy
May 8, 2026BTIGReiteratedBuyBuy
Apr 22, 2026BTIGReiteratedBuyBuy
Mar 11, 2026BTIGMaintainedBuyBuy
Mar 11, 2026Wells FargoMaintainedOverweightOverweight
Feb 2, 2026Wells FargoInitiated—Overweight
Dec 9, 2025HC Wainwright & Co.MaintainedBuyBuy
Dec 8, 2025BTIGReiteratedBuyBuy
Nov 19, 2025BTIGInitiated—Buy
Nov 7, 2025CitizensMaintainedMarket OutperformMarket Outperform
Sep 16, 2025Truist SecuritiesInitiated—Buy
Sep 8, 2025HC Wainwright & Co.MaintainedBuyBuy
Aug 6, 2025HC Wainwright & Co.Initiated—Buy
Jul 8, 2025JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Apr 8, 2025JMP SecuritiesInitiated—Market Outperform
Oct 18, 2024Jones TradingInitiated—Buy